DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE. Mediterr J Hematol Infect Dis 2020, 12 (1), e2020016. https://doi.org/10.4084/mjhid.2020.016.